Instil Bio, Inc. Stock Issued During Period, Shares, Conversion of Convertible Securities
Instil Bio, Inc. (TIL) had Stock Issued During Period, Shares, Conversion of Convertible Securities of 89.22 million shares as of 2021-03-23, per its 10-K filed 2023-03-31.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2023-03-31
- 2021-03-23: Stock Issued During Period, Shares, Conversion of Convertible Securities 89.22M shares.
- 2021-03-19: Stock Issued During Period, Shares, Conversion of Convertible Securities 89.22M shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities |
|---|---|
| 2021-03-23 | 89.22M shares 10-K · filed 2023-03-31 |
| 2021-03-19 | 89.22M shares 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |